Mexico’s annual inflation accelerated more than expected in February, after the central bank paused an extended easing cycle to assess the impact of new taxes and tariffs. Consumer prices rose 4.02% in February compared to the same month last year, according to the national statistics institute. The reading came in above the 3.94% median estimate of analysts surveyed by Bloomberg and up from Janua...
Mexico’s annual inflation accelerated more than expected in February, after the central bank paused an extended easing cycle to assess the impact of new taxes and tariffs. Consumer prices rose 4.02% in February compared to the same month last year, according to the national statistics institute. The reading came in above the 3.94% median estimate of analysts surveyed by Bloomberg and up from January’s 3.79% print. Core inflation , which excludes volatile food and fuel prices, slowed slightly to 4.50% from a year ago, compared to 4.52% in January, in line with the 4.5% median estimate. The central bank targets 3% inflation, plus or minus one percentage point. Banxico, as the central bank is known, kept its key rate at 7% in a unanimous decision at its last meeting on Feb. 5 after delivering 12 straight cuts from 11% over 18 months. Policymakers cited “a higher-than-anticipated trajectory for core inflation” for deciding to pause and also revised their estimate of when consumer prices would converge to target to the second quarter of 2027. Tomatoes, potatoes, and other root vegetables, as well as lunch stalls, diners, torta shops, and taco restaurants had the largest price increases in February. On the contrary, LP domestic gas, eggs, and chicken decreased in price. Banxico Governor Victoria Rodriguez Ceja said last month there’s been no secondary effect on prices stemming from the recent tax hikes on products including sweetened drinks and cigarettes. She added that the government’s newly enacted tariffs on Asian imports haven’t affected prices, supporting market expectations that Banxico will cut the interest rate at its next meeting on March 26. “Core inflation came in line with expectations, confirming no evidence from Asian tariffs at this stage,” said Marco Oviedo , senior strategist at XP Investimentos in a note to clients. “This would be sufficient for the board to start discussing a potential cut in the March meeting, as recent market volatility should be per...
UAE, Kuwait and later Saudi Arabia announced that they are curbing oil output as the impact of the near-closure of the crucial Strait of Hormuz rips through energy markets. Crude surged past $100 per barrel in early trading with Brent futures nearing $120 before paring gains. Meanwhile, European natural gas futures jumped as much as 30%, extending its biggest weekly advance since the start of the ...
UAE, Kuwait and later Saudi Arabia announced that they are curbing oil output as the impact of the near-closure of the crucial Strait of Hormuz rips through energy markets. Crude surged past $100 per barrel in early trading with Brent futures nearing $120 before paring gains. Meanwhile, European natural gas futures jumped as much as 30%, extending its biggest weekly advance since the start of the Iran conflict. Elsewhere, Iran selected Mojtaba Khamenei, the hardline son of the assassinated Ayatollah Ali Khamenei, as its new supreme leader, signaling Tehran won’t back down in a war now raging across the Middle East and causing turmoil in energy markets. The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Lizzy Burden and Tom Mackenzie. (Source: Bloomberg)
syahrir maulana/iStock via Getty Images Portfolio Review Stocks advanced. The U.S. government shutdown that began in October and dragged into November did not deter investors, even as it delayed or eliminated the release of key economic data. U.S. stocks rose during the quarter. Large-cap stocks slightly outperformed small-cap stocks, and both outperformed mid-cap stocks. Value style stocks outper...
syahrir maulana/iStock via Getty Images Portfolio Review Stocks advanced. The U.S. government shutdown that began in October and dragged into November did not deter investors, even as it delayed or eliminated the release of key economic data. U.S. stocks rose during the quarter. Large-cap stocks slightly outperformed small-cap stocks, and both outperformed mid-cap stocks. Value style stocks outperformed growth-style stocks across the market-capitalization spectrum. Both the economy and corporate earnings surged. The economy advanced at an annualized rate of 4.3% in the third quarter, compared with 3.8% in the second quarter. Corporate earnings also advanced. Inflation moderated, but unemployment rose to 4.6% in November, the highest since September 2021. The Federal Reserve lowered its benchmark rate by 0.25% twice in response to the weakness in the labor market. Health care lagged. Our relative underperformance was due to both allocation decisions and stock selection. Biotechnology, pharmaceuticals and life sciences tools and services stocks rallied near the end of the quarter, and our lack of exposure to these outperforming industries hindered results as many of these companies are not yet profitable and we believe they don't meet our requirements for investment. Positions in Embecta and Enovis also underperformed. Materials underperformed. Metals and mining companies outperformed due to strong base metals prices. As a result, our lack of exposure to companies in this industry hampered results compared to the benchmark. A large position in Graphic Packaging Holding also detracted due to weaker-than-expected unit volumes and an abrupt change in its CEO. Information technology contributed. While the sector's outperformance was mostly due to avoidance of bitcoin miners, stock selection also contributed. Strong results from Amkor Technology and Kulicke & Soffa Industries more than offset weakness in Axcelis Technologies, which declined following the announcement of an...
Anthropic (ANTH.PVT) continued to clash with the Defense Department after the artificial intelligence startup was notified that it was designated a "supply chain risk for national security" by the US government. In a blog post, Anthropic CEO Dario Amodei vowed to fight the action, which is usually reserved for foreign adversaries, writing that Anthropic has "no choice but to challenge it in court....
Anthropic (ANTH.PVT) continued to clash with the Defense Department after the artificial intelligence startup was notified that it was designated a "supply chain risk for national security" by the US government. In a blog post, Anthropic CEO Dario Amodei vowed to fight the action, which is usually reserved for foreign adversaries, writing that Anthropic has "no choice but to challenge it in court." In the post, Amodei also said he resumed negotiations with the Defense Department to put a military contract back on the table. OpenAI (OPAI.PVT) reached a deal with the government last week, which elicited pushback from employees and users, including the lab's hardware and robotics leader, Caitlin Kalinowski, who resigned over concerns about the deal with the Pentagon. Anthropic and OpenAI were also in focus after Nvidia (NVDA) CEO Jensen Huang's suggestion that the chipmaker's multibillion-dollar investments in the startups could be the last of their kind for a while. Nvidia has also reportedly halted production of China-bound H200 chips, the Financial Times reported, as regulatory efforts in Washington and Beijing have restricted imports to the Chinese market. And earlier this week, tech watchers were also treated to a slew of product announcements from Apple (AAPL). The product release list included a new low-cost MacBook Neo computer, an entry-level iPhone 17e smartphone, two new iPad Airs, and new MacBook Air and MacBook Pro laptops with more powerful M5 chips. Follow along for the latest updates on the tech sector. LIVE 57 updates
Funtap/iStock via Getty Images Geopolitical events dominated the first trading week of March 2026. The start of U.S. and Israeli military operations against Iran prompted a sharp rise in oil prices as Iran's military launched ballistic missile attacks against Persian Gulf nations and threatened shipping traffic through the strategic chokepoint of the Strait of Hormuz. That escalation prompted mari...
Funtap/iStock via Getty Images Geopolitical events dominated the first trading week of March 2026. The start of U.S. and Israeli military operations against Iran prompted a sharp rise in oil prices as Iran's military launched ballistic missile attacks against Persian Gulf nations and threatened shipping traffic through the strategic chokepoint of the Strait of Hormuz. That escalation prompted marine insurers to cancel war risk coverage for oil container ships, which, in turn, sharply reduced shipments of oil out of the Persian Gulf as shippers were unwilling to risk transiting the strait. The resulting new constraint on the 20% of global oil supply that is transported from the oil-rich nations of the Persian Gulf caused the global price of oil to jump over ten percent . The increase in oil prices put central banks on notice to combat inflation. In the U.S., the prospects for additional interest rate cuts by the Federal Reserve during 2026 dimmed in response to the development. The CME Group's FedWatch Tool projects the Fed will delay an expected quarter-point reduction in the Federal Funds Rate until 29 July (2026-Q3), six weeks later than what was anticipated a week earlier. The tool also projects another quarter-point rate cut on 9 December (2026-Q4). The effect on stock prices, however, was more muted. The S&P 500 ( SPX ) declined 2.0% from its previous week's close to end the trading week at 6,740.02 . The latest update of the alternative futures chart shows the trajectory of the index is still within the red zone forecast range we introduced in the previous edition of the S&P 500 chaos series, but instead of being in the middle, it moved near the lower end of the range. Although geopolitics delivered the week's biggest news, other news influenced investor expectations of the future as well. Here are the week's market-moving headlines: Monday, 2 March 2026 Signs and portents for the U.S. economy: Oil jumps to multiyear high as Hormuz disruption shakes global sup...
Key Points Applied Digital is growing at a rapid pace. It wasn't the only stock position Nvidia exited in Q4. 10 stocks we like better than Applied Digital › Nvidia (NASDAQ: NVDA) isn't just a company that makes graphics processing units (GPUs). It also invests in other tech companies that it sees potential in, and one of those was Applied Digital (NASDAQ: APLD). However, Nvidia recently sold its ...
Key Points Applied Digital is growing at a rapid pace. It wasn't the only stock position Nvidia exited in Q4. 10 stocks we like better than Applied Digital › Nvidia (NASDAQ: NVDA) isn't just a company that makes graphics processing units (GPUs). It also invests in other tech companies that it sees potential in, and one of those was Applied Digital (NASDAQ: APLD). However, Nvidia recently sold its entire stake in the data center operator, which seems like a huge red flag. Is there something else going on here? Or do investors have a reason to be concerned by Nvidia's latest move? Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Portfolio adjustments aren't uncommon for Nvidia We know Nvidia's investment activity because it has a portfolio of equity investments greater than $100 million. As a result, it is required to file a Form 13F with the Securities and Exchange Commission to disclose its end-of-quarter holdings 45 days after each quarter ends. So, the information that we know now reflects its portfolio as of Dec. 31, 2025. As of the end of the third quarter, Nvidia owned around 7.7 million shares of Applied Digital, a stake valued at about $177 million at the time. However, it sold all of those shares during Q4. While investors may be concerned about what led Nvidia to unload that stake, such moves aren't uncommon for the chipmaker. It closed its similarly sized position in ARM Holdings last quarter as well. And at the start of 2025, it did the same thing with its stake in SoundHound AI. Yet just because Nvidia isn't always a long-term investor in tech companies doesn't mean that you can't be. The future is still bright for Applied Digital, which builds and operates high-performance computing data centers. The artificial intelligence (AI) infrastructure buildout is continuing at a strong pace as...
Korro Bio ( KRRO ) has entered into a subscription agreement for a private investment in public equity financing for gross proceeds of approximately $85 million. Pursuant to the terms of the subscription agreement, Korro is selling an aggregate of 4.50M shares of its common stock at a purchase price of $11.11 per share and pre-funded warrants to purchase 3.15M shares of its common stock at a price...
Korro Bio ( KRRO ) has entered into a subscription agreement for a private investment in public equity financing for gross proceeds of approximately $85 million. Pursuant to the terms of the subscription agreement, Korro is selling an aggregate of 4.50M shares of its common stock at a purchase price of $11.11 per share and pre-funded warrants to purchase 3.15M shares of its common stock at a price of $11.109 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.001 per share. The net proceeds from the PIPE financing, together with Korro’s unaudited cash, cash equivalents and marketable securities of $85.2 million as of December 31, 2025, will extend Korro’s cash runway into the second half of 2028 and advance its pipeline of potentially transformational therapies for genetic diseases being discovered by OPERA ® , the company’s novel RNA editing platform, with the remainder used for working capital and general corporate purposes. The PIPE funds clinical development milestones for key pipeline assets including clinical data for KRRO-121 and Korro’s GalNAc-conjugated alpha-1 antitrypsin deficiency (AATD) program, subject to regulatory filings. In addition, the funding enables the advancement of Korro’s longevity and liver health program targeting activation of the AMPKγ1 pathway. KRRO +23.35% premarket to $13.79. Source: Press Release More on Korro Bio Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Seeking Alpha’s Quant Rating on Korro Bio Historical earnings data for Korro Bio
SAN JOSE, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries, today announced it has entered into a multi-year license agreement with Advanced Micro Devices (AMD) for access to Adeia’s comprehensive semiconductor intellectual prope...
SAN JOSE, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries, today announced it has entered into a multi-year license agreement with Advanced Micro Devices (AMD) for access to Adeia’s comprehensive semiconductor intellectual property (IP) portfolio. The agreement also resolves all outstanding litigation between the companies. "We are pleased to reach this agreement with AMD, a global leader in high-performance computing and advanced semiconductor solutions,” said Paul E. Davis, chief executive officer of Adeia. "Resolving our disputes allows both companies to move forward and creates an opportunity for exploring future collaborations on advanced semiconductor technologies.” Adeia has pioneered fundamental advances in the semiconductor industry over the last 30 years. With a large and growing portfolio of intellectual property covering hybrid bonding, semiconductor packaging and semiconductor processing technologies, Adeia licenses and partners with leading semiconductor companies around the world. About Adeia Inc. Get the latest news delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy Adeia (Nasdaq: ADEA) is the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries. We invent and license foundational technologies that shape the future of digital entertainment, electronics, and high-performance computing. Our portfolio transforms technologies into an experience that is intelligent, immersive, and personal. For more, please visit www.adeia.com. For Information Contact: Advertisement Adeia Investor Relations Chris Chaney [email protected] Adeia Media Relations Advertisement Dr. Ma...
Four-time Formula 1 world champion Max Verstappen will tick off one of his "bucket list" events to compete in the Nurburgring 24-Hours endurance race. The 28-year-old Red Bull F1 driver will get behind the wheel of a Mercedes AMG GT car at the event in May, which sees showroom-style cars take on the famous 15.8-mile circuit in the Eifel mountains in Germany. The Dutchman, who finished sixth in Sun...
Four-time Formula 1 world champion Max Verstappen will tick off one of his "bucket list" events to compete in the Nurburgring 24-Hours endurance race. The 28-year-old Red Bull F1 driver will get behind the wheel of a Mercedes AMG GT car at the event in May, which sees showroom-style cars take on the famous 15.8-mile circuit in the Eifel mountains in Germany. The Dutchman, who finished sixth in Sunday's season-opening Australian Grand Prix, said: "The Nurburgring Nordschleife is a special place. There's no other track like it. The 24-hours of Nurburgring is a race that's been on my bucket list for a long time, so I'm really thrilled we can make it happen now." It is very rare for an F1 driver to take part in a lower level motorsport event, especially of Verstappen's calibre, but he has long-enjoyed driving on motorsport simulator games and has a particular affinity with sportscar racing. It is widely considered Verstappen could one day compete at the Le Mans 24-Hours,, external an event which has exploded in popularity in recent years thanks to the introduction of new 'hypercar' regulations, which has seen the likes of Ferrari, Peugeot, Aston Martin and Ford return to the top level of sportscars. The revered Nurgburgring 24-hours is a level below races such as Le Mans, which is part of the World Endurance Championship, which last week announced it will postpone the season-opening Qatar 1812km race because the US-Israeli war against Iran., external Verstappen is contracted with Red Bull until 2028, but had previously been linked with the Mercedes F1 programme. The Nurburgring 24 Hours takes place on 16-17 May, between the Miami and Canadian Grands Prix.
Acco Brands (ACCO) came out with quarterly earnings of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +0.88%. A quarter ago, it was expected that this maker of office supplies would post earnings of $0.22 per share when ...
Acco Brands (ACCO) came out with quarterly earnings of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +0.88%. A quarter ago, it was expected that this maker of office supplies would post earnings of $0.22 per share when it actually produced earnings of $0.21, delivering a surprise of -4.55%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Acco, which belongs to the Zacks Consumer Products - Discretionary industry, posted revenues of $428.8 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.73%. This compares to year-ago revenues of $448.1 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Acco shares have added about 4.8% since the beginning of the year versus the S&P 500's decline of 1.5%. What's Next for Acco? While Acco has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earning...
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.71%. A quarter ago, it was expected that this company would post a loss of $0.59 per share when...
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.71%. A quarter ago, it was expected that this company would post a loss of $0.59 per share when it actually produced a loss of $0.74, delivering a surprise of -25.42%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Dianthus Therapeutics, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.33 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 5.36%. This compares to year-ago revenues of $0.46 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Dianthus Therapeutics, Inc. Shares have added about 11.7% since the beginning of the year versus the S&P 500's decline of -4.5%. What's Next for Dianthus Therapeutics, Inc. While Dianthus Therapeutics, Inc. Has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impress...
(RTTNews) - FTI Consulting Inc. (FCN), a business advisory firm, on Monday appointed Angela Nam as Chief Financial Officer, effective May 1. The company said Nam will also serve as a member of its Executive Committee and will be based in New York. Nam most recently served as Chief Financial Officer and Chief Accounting Officer of FTAI Aviation Ltd., where she oversaw finance and accounting functio...
(RTTNews) - FTI Consulting Inc. (FCN), a business advisory firm, on Monday appointed Angela Nam as Chief Financial Officer, effective May 1. The company said Nam will also serve as a member of its Executive Committee and will be based in New York. Nam most recently served as Chief Financial Officer and Chief Accounting Officer of FTAI Aviation Ltd., where she oversaw finance and accounting functions including financial planning and analysis, financial reporting, tax and treasury. Paul Linton will continue to serve as Interim Chief Financial Officer until Nam assumes the role, after which he will return to his position as Chief Strategy and Transformation Officer. Previously, Ajay Sabherwal, who had served as CFO since 2016, resigned effective September 12, 2025, to take a position outside the consulting industry. Paul Linton took over as Interim CFO. In the pre-market trading, FTI Consulting is 0.02% higher at $168.41 on the New York Stock Exchange. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Rice Hall James & Associates, LLC disclosed a buy of 122,430 shares of Stride (NYSE:LRN) in the fourth quarter. According to a Securities and Exchange Commission (SEC) filing dated Feb. 13, 2026, Rice Hall James & Associates, LLC increased its position in Stride by 122,430 shares. The quarter-end position value for Stride fell by $17.7 million, reflecting both the additional shares and price movem...
Rice Hall James & Associates, LLC disclosed a buy of 122,430 shares of Stride (NYSE:LRN) in the fourth quarter. According to a Securities and Exchange Commission (SEC) filing dated Feb. 13, 2026, Rice Hall James & Associates, LLC increased its position in Stride by 122,430 shares. The quarter-end position value for Stride fell by $17.7 million, reflecting both the additional shares and price movements during the period. Stride is a leading provider of online and blended education services, leveraging proprietary technology platforms to deliver scalable, individualized learning solutions. The company’s diversified offerings span K-12 education, career readiness, and adult workforce training, positioning it as a comprehensive partner for institutions and learners seeking flexible, high-quality educational experiences. With a broad customer base and a focus on both academic and career outcomes, Stride maintains a competitive edge through its integrated service model and commitment to innovation. Continue reading